drugset / Trial / NCT04051268
Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)
RandomizedParallel-groupDouble-blindPrevention
Summary
Phase III study, Randomized, observer blind, lot to lot consistency, non inferiority to PQed typhoid conjugate vaccine and Typhoid Vi polysaccharide vaccine.
Timeline
- Start
- 2020-03-02
- Primary completion
- 2021-11-24
- Completion
- 2021-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | PQed Typhoid Conjugate Vaccine | Vaccine | 0.5 ml | — |
| Comparator | Vi Polysaccharide Vaccine | Vaccine | 0.5 ml | — |
| Subject | Vi-DT Typhoid Conjugate Vaccine | Vaccine | 0.5 ml | — |
Indications
No indication recorded.